Please use this identifier to cite or link to this item:
Type: Artigo de periódico
Title: Is the Immunohistochemical Expression of Proliferation (Ki-67) and Apoptosis (Bcl-2) Markers and Cyclooxigenase-2 (COX-2) Related to Carcinogenesis in Postmenopausal Endometrial Polyps?
Author: Antunes, Armando, Jr.
Andrade, Liliana A. L. A.
Pinto, Glauce A.
Leao, Rogerio
Pinto-Neto, Aarao M.
Costa-Paiva, Lucia
Abstract: OBJECTIVE: To evaluate the pattern of Ki-67, Bcl-2 and COX-2 expression in the glandular epithelium and stroma of malignant and benign endometrial polyps in post-menopause. STUDY DESIGN: A total of 390 postmenopausal women underwent surgical hysteroscopy; women with endometrial polyps were included. Polypoid lesions were histologically classified as benign, premalignant or malignant lesions. Ki-67, Bcl-2 and COX-2 expression were evaluated by immunohistochemistry according to percentage of stained cells, staining intensity, and final score. RESULTS: The prevalence of malignancy in endometrial polyps was 7.1% and was associated with postmenopausal bleeding. The final score showed that only mean COX-2 expression was higher in malignant polyps both in the glandular epithelium (6.1 +/- 2.5) (p < 0.001) and stroma (2.4 +/- 3.0) (p < 0.01). There was a higher Bcl-2 expression, especially in the glandular epithelium, with no differences between benign polyps and premalignant/malignant polyps. Ki-67 expression was low in both benign polyps and premalignant/malignant polyps. CONCLUSION: Polyps in postmenopause have a high COX-2 expression that is higher in malignant polyps than in benign polyps. There was no difference in Ki-67 and Bcl-2 expression between malignant polyps and premalignant/malignant polyps. (Anal Quant Cytopathol Histopathol 2012;34:264-272)
Subject: Bcl-2
endometrial polyp
Editor: Sci Printers & Publ Inc
Rights: fechado
Date Issue: 2012
Appears in Collections:FCM - Artigos e Outros Documentos

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.